IDXX

Conviction 20HealthcareScan · Thu, Jun 25, 2026

IDXX$554.93+1.05%

ResistanceSupportVol 14Congress buyCongress sell

Vol MA14 658.43K

Mar 26Apr 14May 1May 19Jun 8Jun 25

IDEXX LABORATORIES INC /DEIN VITRO & IN VIVO DIAGNOSTIC SUBSTANCESwww.idexx.com ↗

Price554.93

Change+1.05%

Gap-0.08%

Rel volume2.07×

Avg volume707.86K

Avg $ vol395.93M

SMA 20559.74

SMA 50559.55

SMA 200630.62

Price vs 50-0.83%

Price vs 200-12.00%

MA stackbearish

50/200 cross—

Supertrenddown · 586.82

RSI (14)49

MACD hist-1.30

MACD crossbear · 3d

Stoch %K / %D38 / 23

ADX (14)12

+DI / −DI21 / 18

RSI divergence—

MACD divergence—

ATR %+3.15%

ADR %2.94%

52w high766.68

52w low514.61

From 52w high-27.62%

Above 52w low+7.83%

New 52w highNo

SqueezeOn · 9d

Bollinger width6.72%

%B0.37

Donchian pos38.31%

Donchian high581.47

Donchian low538.44

AVWAP (52w high)613.89

vs AVWAP high-9.61%

AVWAP (52w low)625.89

vs AVWAP low-11.34%

OBV trendUp

Chaikin MF (20)-0.04

Today vs 20d2.07×

Avg vol (14d)658.43K

Avg vol (20d)707.86K

Avg $ vol (20d)395.93M

Market cap43.77B

RS 3m (vs SPY)-15.95%

RS 6m (vs SPY)-29.32%

RS line new highNo

Trend template0/8

Technical rank33.5

1 week+1.62%

1 month-0.41%

3 months-3.61%

6 months-20.96%

1 year+4.60%

YTD-17.17%

P/E41.32

P/B28.13

P/S10.17

P/FCF41.41

EPS13.08

Div yield—

ROE68.08%

ROA31.29%

Debt/Eq0.29

Current1.12

EV/EBITDA29.25

Gross margin61.80%

Net margin24.62%

Rev growth10.42%

EPS growth19.33%

Price target703.67

Target upside26.80%

Analyst ratingBuy

Institutional104.94%

Ent. value44.02B

Revenue1.14B

Net income278.45M

Gross profit722.74M

Free cash flow1.06B

IndustryIN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES

ExchangeNasdaq

Shares out78.88M

Employees11K

ListedFri, Jun 21, 1991

Free float78.58M

Float %99.6%

Short interest2.18M

Days to cover3.4d

Short volume54.7%

Squeeze score47 / 100

Next earningsMon, Aug 3, 2026 (39d)

EPS forecast$3.95 · 6 est

Last EPS vs est$3.47 vs $3.42

Last surprise+1.5% beat

Setup gradeD

Conviction20 / 100

Pattern quality—

Tech rank33.5 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance583.30

Support530.91

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Signal lifecycle

How this symbol has moved through the lanes across 17 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.

Breaking out now
Jun 9
1 scan
→
Setting up
Jun 15 – Jun 16
2 scans

Congress activity

Disclosed STOCK Act trades in IDXX · 10 recent

All disclosures →

Member	Side	Amount	Traded	Filed	PTR
April McClain Delaney house · D · MD · traded 2026-01-13	Sell	$1K–$15K	2026-01-13	2026-02-02	PDF
Byron Donalds house · R · FL · traded 2025-09-04	Buy	$1K–$15K	2025-09-04	2025-10-07	PDF
April McClain Delaney house · D · MD · traded 2025-08-07	Sell	$1K–$15K	2025-08-07	2025-09-02	PDF
April McClain Delaney house · D · MD · traded 2025-07-09	Sell	$1K–$15K	2025-07-09	2025-08-05	PDF
Jefferson Shreve house · R · IN · traded 2025-05-12	Sell	$100K–$250K	2025-05-12	2025-06-22	PDF
Rob Bresnahan house · PA · traded 2025-05-15	Buy	$1K–$15K	2025-05-15	2025-06-09	PDF
Jefferson Shreve house · R · IN · traded 2025-04-07	Buy	$50K–$100K	2025-04-07	2025-05-08	PDF
April McClain Delaney house · D · MD · traded 2025-04-09	Buy	$1K–$15K	2025-04-09	2025-05-02	PDF
April McClain Delaney house · D · MD · traded 2025-04-04	Buy	$1K–$15K	2025-04-04	2025-05-02	PDF
April McClain Delaney house · D · MD · traded 2025-04-07	Buy	$1K–$15K	2025-04-07	2025-05-02	PDF

Insider activity

SEC Form 4 transactions in IDXX · 8 buys · 2 sells

Insider	Side	Shares	Value	Traded	Filed
FENNELL GEORGE Executive Vice President · Restricted Stock Unit · 2026-06-01	Exercise	639	—	2026-06-01	2026-06-02
FENNELL GEORGE Executive Vice President · Common Stock · 2026-06-01	Tax	284	$161K	2026-06-01	2026-06-02
FENNELL GEORGE Executive Vice President · Common Stock · 2026-06-01	Exercise	639	$0	2026-06-01	2026-06-02
Kingsley Lawrence D Director · Non-Qualified Stock Option (right-to-buy) · 2026-05-12	Grant	525	$0	2026-05-12	2026-05-14
ESSIG STUART Director · Non-Qualified Stock Option (right-to-buy) · 2026-05-12	Grant	525	$0	2026-05-12	2026-05-14
SAMAD SAM Director · Non-Qualified Stock Option (right-to-buy) · 2026-05-12	Grant	525	$0	2026-05-12	2026-05-14
ESSIG STUART Director · Restricted Stock Unit · 2026-05-12	Grant	234	$0	2026-05-12	2026-05-14
HOOLEY JOSEPH L Director · Non-Qualified Stock Option (right-to-buy) · 2026-05-12	Grant	525	$0	2026-05-12	2026-05-14
Britt Irene Chang Director · Non-Qualified Stock Option (right-to-buy) · 2026-05-12	Grant	525	$0	2026-05-12	2026-05-14
JUNIUS DANIEL M Director · Restricted Stock Unit · 2026-05-12	Grant	234	$0	2026-05-12	2026-05-14

SEC filings

EDGAR filings in IDXX

EDGAR →

No recent SEC filings on file for IDXX.

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.